Jie Wu

机构：China Academy of Chinese Medical Sciences, Guang’anmen Hospital, First Affiliated Hospital of Jinan University · ORCID：0000-0001-5664-599X

发表论文 95 篇 · 总被引 1357 次 · h-index 21

代表论文

• Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid (2024 · Science Translational Medicine · 被引 98)
• Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis (2023 · Journal for ImmunoTherapy of Cancer · 被引 63)
• Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1 (2023 · Cell Death and Disease · 被引 55)
• Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma (2024 · Biomaterials · 被引 22)
• In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia (2023 · Infection and Drug Resistance · 被引 11)